PREDICTIVE ONCOLOGY INC (POAI) Stock Analyst Earnings Estimates
NASDAQ:POAI - Nasdaq - US74039M3097 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.51M 6.34% | 1.628M 7.79% | 1.624M -0.24% | 9.52M 486.28% | 15.756M 65.50% | 24.448M 55.17% | |
| EBITDA YoY % growth | -13.95M -15.00% | -11.71M 16.06% | -10.777M 7.96% | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.26M -13.29% | -11.955M 21.66% | -10.94M 8.49% | -1.895M 82.68% | 1.58M 183.37% | 6.983M 341.96% | |
| Operating Margin | -1,010.60% | -734.46% | -673.70% | -19.91% | 10.03% | 28.56% | |
| EPS YoY % growth | N/A 14.54% | N/A 61.29% | N/A -1,633.33% | -0.13 93.75% | 0.08 161.54% | 0.28 237.50% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.09 | -0.09 80.88% | 0.06 125.50% |
| Revenue Q2Q % growth | 1.53M 448.98% | 1.53M 342.20% | 5.1M 733.33% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.34 | -0.09 | -0.25 | -270.37% |
| Q4 2024 Q2Q % growth | -0.24 | -0.26 | 0.02 | 5.88% |
| Q3 2024 Q2Q % growth | -0.48 | -0.33 | -0.15 | -47.06% |
| Q4 2022 Q2Q % growth | 52.92% | -0.06 | % | |
| Q3 2022 Q2Q % growth | -0.05 37.50% | -0.01 | -0.04 | -390.20% |
| Q2 2022 Q2Q % growth | -0.15 -200.00% | -0.03 | -0.12 | -390.20% |
| Q1 2022 Q2Q % growth | -1.00 -809.09% | -0.82 | -0.18 | -22.55% |
| Q4 2021 Q2Q % growth | -0.13 81.43% | -0.03 | -0.10 | -409.80% |
| Q3 2021 Q2Q % growth | -0.08 | -0.05 | -0.03 | -56.86% |
| Q2 2021 Q2Q % growth | -0.05 | -0.08 | 0.03 | 34.64% |
| Q1 2021 Q2Q % growth | -0.11 | -0.09 | -0.02 | -19.83% |
| Q4 2020 Q2Q % growth | -0.70 | -0.18 | -0.52 | -281.26% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 110.31K -73.72% | 1.53M | -1.42M | -92.79% |
| Q4 2024 Q2Q % growth | 612K 82.69% | 357K | 255K | 71.43% |
| Q3 2024 Q2Q % growth | 346K -51.94% | 510K | -164K | -32.16% |
| Q2 2024 Q2Q % growth | 278.7K -43.12% | % | ||
| Q1 2024 Q2Q % growth | 419.7K 74.88% | % | ||
| Q4 2023 Q2Q % growth | 335K -6.94% | % | ||
| Q3 2023 Q2Q % growth | 720K 56.52% | % | ||
| Q2 2023 Q2Q % growth | 490K 32.43% | % | ||
| Q1 2023 Q2Q % growth | 240K -22.58% | % | ||
| Q4 2022 Q2Q % growth | 360K -25.00% | 510K | -150K | -29.41% |
| Q3 2022 Q2Q % growth | 460K 48.39% | 4.08M | -3.62M | -88.73% |
| Q2 2022 Q2Q % growth | 370K 5.71% | 2.04M | -1.67M | -81.86% |
| Q1 2022 Q2Q % growth | 310K 10.71% | 1.02M | -710K | -69.61% |
| Q4 2021 Q2Q % growth | 480K 65.52% | 2.55M | -2.07M | -81.18% |
| Q3 2021 Q2Q % growth | 310K -35.42% | 1.224M | -914K | -74.67% |
| Q2 2021 Q2Q % growth | 350K 94.44% | 612K | -262K | -42.81% |
| Q1 2021 Q2Q % growth | 280K -3.45% | 357M | -356.72M | -99.92% |
| Q4 2020 Q2Q % growth | 290K -17.14% | 357M | -356.71M | -99.92% |
| Q3 2020 Q2Q % growth | 480K -7.69% | % | ||
| Q2 2020 Q2Q % growth | 180K -37.93% | % | ||
| Q1 2020 Q2Q % growth | 290K 11.54% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |